DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 018299
The generic ingredient in VIROPTIC is trifluridine. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the trifluridine profile page.
Summary for 018299
Tradename: | VIROPTIC |
Applicant: | Monarch Pharms |
Ingredient: | trifluridine |
Patents: | 0 |
Therapeutic Class: | Antivirals |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 018299
Ingredient-type | Nucleoside Analog |
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 018299
Suppliers and Packaging for NDA: 018299
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VIROPTIC | trifluridine | SOLUTION/DROPS;OPHTHALMIC | 018299 | NDA | Pfizer Laboratories Div Pfizer Inc | 61570-037 | N | 61570-037-75 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 1% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AT | RLD: | Yes |
Complete Access Available with Subscription